153
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1870-1874 | Received 03 Apr 2023, Accepted 10 Jul 2023, Published online: 25 Jul 2023
 

Authors’ contribution

DARG, JCM, BAS, and NLB designed the research. DARG, JCM, BRC, and MPW collected the data. DARG, JCM, and NW analyzed the data. DARG, JCM, MPW, BAS, and NLB wrote the manuscript.

Disclosure statement

NLB receives research funding from Autolus, Celgene/Bristol Myers-Squibb, Forty-Seven, Janssen, Kite/Gilead, Merck, Millennium, and Pharmacyclics, and serves as a consultant/advisor for ADC Therapeutics, Genentech/Roche, and Seattle Genetics. BAS serves as a consultant for Curium Pharma, Lantheus Medical, Capella Imaging, and GE Healthcare.

Additional information

Funding

The authors received no specific funding for this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.